Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol

BACKGROUND: ‘Clinically important deterioration’ (CID) is a composite endpoint measuring worsening of the key clinical features of chronic obstructive pulmonary disease (COPD), namely lung function, patient-reported outcomes, and exacerbations. ACLIFORM and AUGMENT were two 24-week, randomized, doub...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Dave, D’Urzo, Anthony D., Chuecos, Ferran, Muñoz, Anna, Garcia Gil, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450266/
https://www.ncbi.nlm.nih.gov/pubmed/28558833
http://dx.doi.org/10.1186/s12931-017-0583-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450266/
https://www.ncbi.nlm.nih.gov/pubmed/28558833
http://dx.doi.org/10.1186/s12931-017-0583-0

Ejemplares similares